United Therapeutics
UTHR • NASDAQ
United Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Martine A. Rothblatt, with a market cap of $25.1B.
Market Cap$25.1B
Employees1.2K
CEOMartine A. Rothblatt
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
UTH
United Therapeutics FAQ
Common questions about United Therapeutics
United Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $797.4M.
United Therapeutics has approximately 1,168 employees.